ESPRIT
Device
Abbott Laboratories
Total Payments
$1.4M
Transactions
3,819
Doctors
1,667
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $803,663 | 3,194 | 1,622 |
| 2023 | $596,754 | 446 | 19 |
| 2021 | $30,288 | 155 | 46 |
| 2020 | $17,461 | 23 | 18 |
| 2019 | $143.01 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $964,353 | 903 | 66.6% |
| Consulting Fee | $282,036 | 73 | 19.5% |
| Food and Beverage | $156,728 | 2,724 | 10.8% |
| Travel and Lodging | $35,389 | 96 | 2.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,669 | 11 | 0.7% |
| Education | $133.36 | 12 | 0.0% |
Payments by Type
Research
$964,353
903 transactions
General
$483,956
2,916 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| LIFE-BTK (Pivotal Investigation of Safety and Efficacy of BRS Treatment-Below The Knee) Randomized Controlled Trial | Abbott Laboratories | $496,626 | 0 |
| LIFE-BTK (pivotaL Investigation of saFety and Efficacy of BRS Treatment-Below The Knee) Randomized Controlled Trial | Abbott Laboratories | $227,768 | 0 |
| Esprit BTK Post-Approval Study (EspritBTKPAS) | Abbott Laboratories | $194,430 | 0 |
| LIFE-BTK Randomized Controlled Trial | Abbott Laboratories | $35,288 | 0 |
| LIFE-BTK Pharmacokinetics (PK) Sub-study | Abbott Laboratories | $5,600 | 0 |
| LIFE-BTK | Abbott Laboratories | $1,585 | 0 |
| Esprit BTK PAS | Abbott Laboratories | $1,405 | 0 |
| LIFE BTK | Abbott Laboratories | $1,250 | 0 |
| LIFE-BTK(pivotaL Investigation of saFety and Efficacy of BRS Treatment-Below The Knee) Randomized Controlled Trial | Abbott Laboratories | $400.00 | 0 |
Top Doctors Receiving Payments for ESPRIT — Page 9
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Cardiovascular Disease | Oklahoma City, OK | $196.71 | 8 |
| , MD | Internal Medicine | Brooklyn, NY | $196.32 | 2 |
| , M.D | Surgery | Louisville, KY | $195.56 | 3 |
| , M.D | Surgery | Rogers, AR | $194.89 | 2 |
| , D.O | Cardiovascular Disease | Weatherford, TX | $194.26 | 2 |
| , M.D | Cardiovascular Disease | Morehead, KY | $193.54 | 2 |
| , M.D | Interventional Cardiology | Oak Lawn, IL | $193.30 | 2 |
| , M.D | Student in an Organized Health Care Education/Training Program | Cincinnati, OH | $193.27 | 2 |
| , D.O | Student in an Organized Health Care Education/Training Program | Columbus, OH | $193.26 | 2 |
| , MD | Surgery | Germantown, TN | $193.13 | 4 |
| , MD | Specialist | Cincinnati, OH | $193.00 | 2 |
| , MD | Vascular Surgery | Tucson, AZ | $192.39 | 2 |
| , MD | Surgery | Bronx, NY | $191.80 | 1 |
| , M.D | Interventional Cardiology | Bronx, NY | $190.74 | 1 |
| , MD | Surgery | New York, NY | $190.74 | 1 |
| Syed Mustafa | Vascular & Interventional Radiology | Newark, NJ | $190.74 | 1 |
| , MD | Vascular Surgery | New York, NY | $190.73 | 1 |
| , MD | Interventional Cardiology | Greenlawn, NY | $189.55 | 1 |
| , M.D | Cardiovascular Disease | New York, NY | $189.55 | 1 |
| , M.D | Interventional Cardiology | New York, NY | $188.89 | 3 |
| , M.D.,F.A.C.C | Cardiovascular Disease | Westminster, CO | $188.51 | 1 |
| , D.O | Cardiovascular Disease | Greenwood Village, CO | $188.50 | 1 |
| , MD | Internal Medicine | Nashville, TN | $186.67 | 1 |
| , MD | Cardiovascular Disease | Sayre, PA | $186.43 | 3 |
| , MD | Cardiovascular Disease | Memphis, TN | $186.32 | 2 |
Ad
Manufacturing Companies
- Abbott Laboratories $1.4M
Product Information
- Type Device
- Total Payments $1.4M
- Total Doctors 1,667
- Transactions 3,819
About ESPRIT
ESPRIT is a device associated with $1.4M in payments to 1,667 healthcare providers, recorded across 3,819 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2024. In 2024, $803,663 was paid across 3,194 transactions to 1,622 doctors.
The most common payment nature for ESPRIT is "Unspecified" ($964,353, 66.6% of total).
ESPRIT is associated with 9 research studies, including "LIFE-BTK (Pivotal Investigation of Safety and Efficacy of BRS Treatment-Below The Knee) Randomized Controlled Trial" ($496,626).